Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    UID:
    b3kat_BV035473188
    Format: 1 Online-Ressource
    ISBN: 9789264014046
    Content: This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries: Belgium, Finland, France, Germany, Japan, the Netherlands, Norway and Spain. The report summarizes the results of in-depth studies, providing a comparative analysis of participating countries performance in science and innovation in biopharmaceuticals. It highlights specific characteristics of the national biopharmaceutical innovation systems in terms of their international openness and the specific role of demand-side factors in the innovation process. Major systemic failures affecting the functioning of the biopharmaceutical innovation systems are identified. Based on evidence, the report draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.--Publisher's description.
    Language: English
    Keywords: Pharmazeutische Technologie ; Biopharmazie ; Innovationsförderung ; Technologiepolitik ; Industriepolitik
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    UID:
    gbv_1648005039
    Format: Online-Ressource (187 p.)
    ISBN: 9789264014046
    Content: This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries - Belgium, Finland, France, Germany, Japan, the Netherlands, Norway and Spain. The report summarises the results of in-depth studies, providing a comparative analysis of participating countries' performance in science and innovation in biopharmaceuticals. It highlights specific characteristics of the national biopharmaceutical innovation systems in terms of their international openness and the specific role of demand-side factors in the innovation process. Major systemic failures affecting the functioning of the biopharmaceutical innovation systems are identified. Based on rich evidence, the report draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.
    Additional Edition: Druckausg. ISBN 9789264014039
    Additional Edition: Erscheint auch als Druck-Ausgabe Innovation in pharmaceutical biotechnology Paris : OECD, 2006 ISBN 9264014039
    Language: English
    Subjects: Economics
    RVK:
    Keywords: OECD ; Biopharmazie ; Industriepolitik ; Pharmazeutische Technologie ; Innovationsförderung ; Technologiepolitik ; Pharmazeutische Technologie ; Biotechnologie ; Innovation ; Biologika
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    UID:
    gbv_510837395
    Format: 187 S. , graph. Darst.
    ISBN: 9264014039
    Note: Literaturangaben , Zsfassung in franz. Sprache , Parallel als Online-Ausg. erschienen
    Additional Edition: Online-Ausg. Innovation in Pharmaceutical Biotechnology Paris : OECD Publishing, 2006 ISBN 9789264014046
    Language: English
    Subjects: Economics
    RVK:
    Keywords: OECD ; Biopharmazie ; Industriepolitik ; Pharmazeutische Technologie ; Innovationsförderung ; Technologiepolitik ; Pharmazeutische Technologie ; Biotechnologie ; Innovation ; Biologika ; Amtsdruckschrift ; Graue Literatur
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    UID:
    gbv_625996240
    Format: Online-Ressource (188 p.)
    ISBN: 9789264014039
    Content: What are the specific characteristics of innovation in pharmaceutical biotechnology? How do biopharmaceutical innovation systems in OECD countries perform and which policies are suitable to foster performance?. This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries - Belgium, Finland, France, Germany, Japan, the Netherlands, Norway and Spain. The report summarises the results of in-depth studies, providing a comparative analysis of participating countries' performance in science and innovation in biopharmaceuticals. It highlights specific charac
    Note: Description based upon print version of record , Foreword; TABLE OF CONTENTS; Executive Summary; Note de synthèse; Chapter 1. Introduction; Chapter 2. Summary of Country Studies; Belgium; Finland; France; Germany; Japan; The Netherlands; Norway; Spain; Chapter 3. Comparison of Performance in National BiopharmaceuticalInnovation Systems; Chapter 4 .Openness of the Biopharmaceutical Innovation System; Chapter 5. Comparison of Selected Demand-side Factors; Chapter 6. Structure, Dynamics and Performance in NationalBiopharmaceutical Innovation Systems; Chapter 7. Systemic Imperfections in Biopharmaceutical Innovation Systems , Chapter 8. Policy Implications
    Additional Edition: ISBN 9789264014046
    Additional Edition: Print version Innovation in Pharmaceutical Biotechnology : Comparing National Innovation Systems at the Sectoral Level
    Language: English
    Keywords: Pharmazeutische Technologie ; Biopharmazie ; Innovationsförderung ; Technologiepolitik ; Industriepolitik ; Electronic books
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    UID:
    edoccha_9958103804102883
    Format: 1 online resource (188 p.)
    ISBN: 1-280-60665-7 , 9786610606658 , 92-64-01404-7
    Content: This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries - Belgium, Finland, France, Germany, Japan, the Netherlands, Norway and Spain. The report summarises the results of in-depth studies, providing a comparative analysis of participating countries' performance in science and innovation in biopharmaceuticals. It highlights specific characteristics of the national biopharmaceutical innovation systems in terms of their international openness and the specific role of demand-side factors in the innovation process. Major systemic failures affecting the functioning of the biopharmaceutical innovation systems are identified. Based on rich evidence, the report draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.
    Note: "The pharmaceutical biotechnology case study comprised eight participating countries: Belgium, Finland, France, Germany, Japan, the Netherlands, Norway and Spain"--Foreword. , Structure, Dynamics and Performance in National Biopharmaceutical Innovation Systems -- Systemic Imperfections in Biopharmaceutical Innovation Systems -- Policy Implications -- Executive Summary -- Introduction -- Summary of Country Studies -- Comparison of Performance in National Biopharmaceutical Innovation Sy -- Openness of the Biopharmaceutical Innovation System. , English
    Additional Edition: ISBN 92-64-01403-9
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Did you mean 9789264014008?
Did you mean 9789264014022?
Did you mean 9789264014060?
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages